- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Hypercholesterolaemia and Mixed Dyslipidaemia in United Kingdom
Total 26622 results
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
GlaxoSmithKlineCompletedHealthy Subjects | Dyslipidaemia | DyslipidaemiasUnited Kingdom
-
Novo Nordisk A/SCompletedHealthy Volunteers | HypercholesterolaemiaUnited Kingdom
-
AstraZenecaTerminatedHypercholesterolaemiaUnited Kingdom
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsUnited Kingdom
-
Xention LtdCompleted
-
Kowa Research EuropeCompletedDyslipidemia | Primary HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
Xention LtdCompleted
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Kowa Research EuropeCompletedHypercholesterolemia or Combined DyslipidemiaDenmark, Israel, Netherlands, Germany, United Kingdom
-
GlaxoSmithKlineCompletedAn Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And InflammationObesity | Hypercholesterolemia | DyslipidaemiasUnited States
-
AbbottCompletedMixed DyslipidemiaUnited States
-
AstraZenecaCompletedDyslipidemia, Hypercholesterolemia, HypertriglyceridemiaUnited States
-
AmgenTerminatedPregnancy | HypercholesterolaemiaBelgium, Denmark, Italy, Czechia, United Kingdom, Australia, Austria, Greece, Switzerland, Netherlands, Spain, Sweden, Slovakia, Norway
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Kowa Research EuropeCompletedDyslipidemia | HypercholesterolemiaFinland, Italy, Norway, Russian Federation, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompleted
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Merck Sharp & Dohme LLCCompletedHypercholesterolaemiaUnited States
-
TakedaCompletedHypercholesterolemiaPoland, United Kingdom, Germany, South Africa, Finland, Estonia, Czech Republic
-
Kowa Research EuropeCompletedStudy of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined DyslipidemiaDyslipidemias | HypercholesterolemiaDenmark, Israel, Germany, Netherlands, United Kingdom
-
AbbottCompletedHyperlipidemia | Mixed DyslipidemiaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
Cumberland PharmaceuticalsCompletedDyslipidemias | HypercholesterolemiaUnited States
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaBelgium, Spain, Germany, Austria, Italy, United States, France, Netherlands, Switzerland, United Kingdom
-
University of ReadingFondazione Edmund Mach di San Michele all'AdigeCompletedMild HypercholesterolemiaUnited Kingdom
-
Ohio State UniversityNational Institute of General Medical Sciences (NIGMS)WithdrawnDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Ohio State UniversityNational Institute on Minority Health and Health Disparities (NIMHD); National...CompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
Novartis PharmaceuticalsCompletedDyslipidaemiaJordan, United States, Taiwan
-
Kowa Research EuropeCompletedDyslipidemia | HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, United States, Australia
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
PfizerCompletedMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | HyperlipidemiasUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
GlaxoSmithKlineCompleted
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedDyslipidemia | HypercholesterolemiaUnited States
-
AstraZenecaCompleted
-
Novo Nordisk A/SRecruitingHealthy Volunteers | DyslipidaemiaUnited States
-
PfizerTerminatedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
PfizerCompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Provident Clinical ResearchGlaxoSmithKlineCompletedPrimary HypercholesterolemiaUnited States